Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. - Preston, Ioana R.; Burger, Charles D.; Bartolome, Sonja; Safdar, Zeenat; Krowka, Michael; Sood, Namita; Ford, Hubert J.; Battarjee, Wejdan F.; Chakinala, Murali M.; Gomberg-Maitland, Mardi; Hill, Nicholas S. (Journal of Heart & Lung Transplantation, 2020)